Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy. (Q40151821)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

17

Satoru Saito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

24

Kazuaki Chayama

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

23

Masataka Tsuge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

26

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

5

Yasuhito Tanaka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

18

Keisuke Hino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Akihiro Matsumoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Shuhei Nishiguchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Hirayuki Enomoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jong-Hon Kang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Noboru Shinkai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Masayuki Kurosaki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Masaru Enomoto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Tatsuo Kanda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Osamu Yokosuka

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Hiroshi Yatsuhashi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Shinya Nagaoka

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Chiaki Okuse

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Tatehiro Kagawa

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Tetsuya Mine

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Koichi Takaguchi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Fusao Ikeda

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Shotaro Sakisaka

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Daisuke Morihara

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Shiho Miyase

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Naoki Hiramatsu

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Kazumoto Murata

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

20 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

247-257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

Management of hepatitis B: summary of a clinical research workshop

23 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Update of research and management of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Antigenic and physicochemical characterization of the 2nd International Standard for hepatitis B virus surface antigen (HBsAg).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleuk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

JSH Guidelines for the Management of Hepatitis B Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Correlation between hepatitis B virus genotypes and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-017-1360-Z

Development of specific and quantitative real-time detection PCR and immunoassays for λ3-interferon

21 January 2018

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

Management of HBV infection in Japan

1 reference

12 December 2020

Sequential treatment with lamivudine and interferon-alpha monotherapies in hepatitis B e antigen-negative Chinese patients and its suppression of lamivudine-resistant mutations

1 reference

12 December 2020

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

1 reference

12 December 2020

Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy

1 reference

12 December 2020

Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.

1 reference

12 December 2020

10.1007/S00535-017-1360-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28634723%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference